Idiosyncratic drug hepatotoxicity
The DOI matches its Crossref record; 154 of the 155 references it cites were found in a registry or an index.
Abstract
The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the most frequent cause of post-marketing warnings and withdrawals. This review examines the clinical signatures of this problem, signals predictive of its occurrence (particularly of more frequent, reversible, low-grade injury) and the role of monitoring in prevention by examining several recent examples (for example, troglitazone). In addition, the failure of preclinical toxicology to predict idiosyncratic reactions, and what can be done to improve this problem, is discussed. Finally, our current understanding of the pathophysiology of experimental drug hepatotoxicity is examined, focusing on acetaminophen, particularly with respect to the role of the innate immune system and control of cell-death pathways, which might provide targets for exploration and identification of risk factors and mechanisms in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current drug development process suffers from a high failure rate during clinical trials, which is partly due to inadequacy of animal models to accurately predict the toxic side-effects of drugs in humans [1,2].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [2]
In the citing paper
“Drug-induced liver injury (DILI) is a common adverse drug reaction (ADR), and it can lead to liver failure and even death.[1][2][3]”
From Incidence and Etiology of Drug-Induced Liver Injury in Mainland China (2019) · cites this paper as [1]
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
Schwartz, G. G. (2001) · JAMA · doi:10.1001/jama.285.13.1711 · Cited by 2,499
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. II. ROLE OF COVALENT BINDING IN VIVO
Jollow, D. J., Mitchell, J. R., Potter, W. Z., Davis, D. C., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29664-1 · Cited by 1,204
Acetaminophen-induced Hepatic Necrosis
Jollow, D. J., Thorgeirsson, S. S., Potter, W. Z., Hashimoto, M., & Mitchell, J. R. (1974) · Pharmacology · doi:10.1159/000136547 · Cited by 1,092
ANDRADE, R., LUCENA, M., FERNANDEZ, M., PELAEZ, G., PACHKORIA, K., GARCIARUIZ, E., GARCIAMUNOZ, B., GONZALEZGRANDE, R., PIZARRO, A., & DURAN, J. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.006 · Cited by 856
Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease
Watkins, P. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370044030 · Cited by 829
Research works printed but not linked: 3
- Nelson, S. D. & Bruschi, S. A. in Drug-Induced Liver Disease (eds Kaplowitz, N. & DeLeve, L.) 287–325 (Marcel Dekker, New York, 2003).
- Chien, J. Y., Thummel, K. E. & Slattery, J. T. Pharmakinetic consequence of induction of CYP2E1 by ligand stabilization. Drug Metab. Dispos. 25, 1165–1175 (1997).
- Liu, Z. -X. & Kaplowitz, N. in Clinics in Liver Disease 6, 467–486 (Elsevier, 2002).
Cited by
Items 401–500 of 999
Are zebrafish larvae suitable for assessing the hepatotoxicity potential of drug candidates?
Mesens, N., Crawford, A. D., Menke, A. L., Hung, P. D., Goethem, F. V., Nuyts, R., Hansen, E., Wolterbeek, A. P. M., Gompel, J. V., de Witte, P. A. M., et al. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3091 · Cited by 37
Liu, C., Sekine, S., & Ito, K. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.04.010 · Cited by 39
Paper supported long-term 3D liver co-culture model for the assessment of hepatotoxic drugs
Wang, Y., Su, W., Wang, L., Jiang, L., Liu, Y., Hui, L., & Qin, J. (2017) · Toxicology Research · doi:10.1039/c7tx00209b · Cited by 36
Xu, Q., Fan, Y., Loor, J. J., Liang, Y., Sun, X., Jia, H., Zhao, C., & Xu, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.601716 · Cited by 34
Maksoud, M. I. A. A., El-Sayyad, G. S., Fayad, E., Alyamani, A. A., Ali, O. A. A., & Elshamy, A. A. (2021) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-021-02132-9 · Cited by 33
Fukushima, Y., Seo, T., Hashimoto, N., Higa, Y., Ishitsu, T., & Nakagawa, K. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.11.035 · Cited by 32
Ye, D., Li, H., Wang, Y., Jia, W., Zhou, J., Fan, J., Man, K., Lo, C., Wong, C., Wang, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep19776 · Cited by 37
Singh, D., Khan, M. A., & Siddique, H. R. (2023) · Phytotherapy Research · doi:10.1002/ptr.8022 · Cited by 39
Lillegard, J. B., Fisher, J. E., Nedredal, G. I., Luebke-Wheeler, J. L., Bao, J., Wang, W., Amoit, B., & Nyberg, S. L. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22651 · Cited by 36
Siegmund, W., Modeß, C., Scheuch, E., Methling, K., Keiser, M., Nassif, A., Rosskopf, D., Bednarski, P. J., Borlak, J. T., & Terhaag, B. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12522 · Cited by 31
Evaluating biological activity of compounds by transcription factor activity profiling
Medvedev, A. V., Moeser, M., Medvedeva, L., Martsen, E., Granick, A., Raines, L. N., Zeng, M., Makarov, S., Houck, K. A., & Makarov, S. S. (2018) · Science Advances · doi:10.1126/sciadv.aar4666 · Cited by 31
Zhao, L., Russo, D. P., Wang, W., Aleksunes, L. M., & Zhu, H. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa005 · Cited by 30
Weersink, R. A., Alvarez‐Alvarez, I., Medina‐Cáliz, I., Sanabria‐Cabrera, J., Robles‐Díaz, M., Ortega‐Alonso, A., García‐Cortés, M., Bonilla, E., Niu, H., Soriano, G., et al. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2108 · Cited by 29
Self-citationEpidemiology and Management of Drug-induced Liver Injury: Importance of the Updated RUCAM
Kobayashi, T., Iwaki, M., Nogami, A., & Yoneda, M. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00067s · Cited by 54
Toyoda, Y., Tamai, M., Kashikura, K., Kobayashi, S., Fujiyama, Y., Soga, T., & Tagawa, Y. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.041137 · Cited by 34
The Role of Metabolic Biomarkers in Drug Toxicity Studies
Schnackenberg, L. K., & Beger, R. D. (2008) · Toxicology Mechanisms and Methods · doi:10.1080/15376510701623193 · Cited by 29
Wu, G., Vashishtha, S. C., & Erve, J. C. L. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100141d · Cited by 30
Wang, P., Yang, Y., Pang, G., Zhang, C., Wei, C., Tao, X., Liu, J., Xu, J. M., Zhang, W., & Shen, Y. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.10.028 · Cited by 30
Lee, J. K., Leslie, E. M., Zamek‐Gliszczynski, M. J., & Brouwer, K. L. R. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.11.020 · Cited by 31
In vitro methods for diagnosing nonimmediate hypersensitivity reactions to drugs.
Mayorga, C., Sanz, M. L., Gamboa, P., Garcia-Aviles, M. C., Fernández, J., & Torres, M. J. (2013) · PubMed · Cited by 38
Wang, Z., Zhang, F., Xiong, J., Mao, Z., & Liu, Z. (2020) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2020.118960 · Cited by 30
Jetten, M. J., Ruiz‐Aracama, A., Coonen, M. L. J., Claessen, S. M. H., van Herwijnen, M. H. M., Lommen, A., van Delft, J. H. M., Peijnenburg, A., & Kleinjans, J. C. S. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1545-2 · Cited by 31
Masson, M. J., Peterson, R. A., Chung, C. J., Graf, M. L. M., Carpenter, L. D., Ambroso, J. L., Krull, D., Sciarrotta, J., & Pohl, L. R. (2006) · Chemical Research in Toxicology · doi:10.1021/tx060190c · Cited by 34
Genetic and Molecular Factors in Drug-Induced Liver Injury: A Review
Pachkoria, K., Lucena, M. I., Molokhia, M., Cueto-Galán, R., Carballo, A. S., Carvajal, A., & Andrade, R. J. (2007) · Current Drug Safety · doi:10.2174/157488607780598287 · Cited by 29
Iruzubieta, P., Arias-Loste, M. T., Barbier-Torres, L., Martinez-Chantar, M. L., & Crespo, J. (2015) · BioMed Research International · doi:10.1155/2015/386186 · Cited by 24
Investigating acetaminophen hepatotoxicity in multi-cellular organotypic liver models
Orbach, S. M., Cassin, M. E., Ehrich, M. F., & Rajagopalan, P. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.03.008 · Cited by 28
Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization
Ashraf, M. N., Asghar, M. W., Rong, Y., Doschak, M. R., & Kiang, T. K. L. (2018) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-018-0533-3 · Cited by 34
Li, L., Shan, S., Kang, K., Zhang, C., Kou, R., & Song, F. (2020) · Human & Experimental Toxicology · doi:10.1177/0960327120961158 · Cited by 32
Poria Attenuates Idiosyncratic Liver Injury Induced by Polygoni Multiflori Radix Praeparata
Gao, D., Pang, J.-Y., Zhang, C.-E., Li, C., Tu, C., Zhang, H., Niu, M., Xiong, Y., Xiao, X., Zhao, K., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00386 · Cited by 28
Clinical and experimental research in antituberculosis drug-induced hepatotoxicity: a review
Baskaran, U. L., & Prince, S. E. (2017) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(17)60319-4 · Cited by 28
In Silico Prediction of Drug-Induced Liver Injury Based on Adverse Drug Reaction Reports
Zhu, X., & Li, S. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx099 · Cited by 28
Hagiya, Y., Kamata, S., Mitsuoka, S., Okada, N., Yoshida, S., Yamamoto, J., Ohkubo, R., Abiko, Y., Yamada, H., Akahoshi, N., et al. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.11.015 · Cited by 30
Takai, S., Higuchi, S., Yano, A., Tsuneyama, K., Fukami, T., Nakajima, M., & Yokoi, T. (2014) · Journal of Applied Toxicology · doi:10.1002/jat.3002 · Cited by 32
Ware, B. R., McVay, M., Sunada, W. Y., & Khetani, S. R. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx059 · Cited by 27
Saad, M. A., Rastanawi, A. A., & El-Yamany, M. F. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.10.069 · Cited by 26
Paniagua, A. C., Amariles, P., Angulo, N., & Restrepo-Garay, M. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2018.11.008 · Cited by 29
Salas‐Silva, S., Kim, Y., Kim, T. H., Kim, M., Seo, D., Choi, J., Factor, V. M., Seo, H. R., Song, Y., Choi, G. S., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122360 · Cited by 30
Cohen, E. B., Patwardhan, M. B., Raheja, R., Alpers, D., Andrade, R. J., Avigan, M., Lewis, J. H., Rockey, D. C., Chui, F., Iacob, A. M., et al. (2024) · Drug Safety · doi:10.1007/s40264-023-01390-5 · Cited by 38
Kamitsuji, S., Matsuda, T., Nishimura, K., Endo, S., Wada, C., Watanabe, K., Hasegawa, K., Hishigaki, H., Masuda, M., Kuwahara, Y., et al. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2015.23 · Cited by 30
Toxicogenomic Biomarkers for Liver Toxicity
Kiyosawa, N., Ando, Y., Manabe, S., & Yamoto, T. (2009) · Journal of Toxicologic Pathology · doi:10.1293/tox.22.35 · Cited by 28
Sakurai, A., Kurata, A., Onishi, Y., Hirano, H., & Ishikawa, T. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.1.71 · Cited by 27
Hosoya, M., & Czysz, K. (2016) · Cells · doi:10.3390/cells5040046 · Cited by 27
Gutkowski, K., Chwist, A., & Hartleb, M. (2011) · Hepatitis Monthly · doi:10.5812/kowsar.1735143x.641 · Cited by 27
Clinical Hepatotoxicity. Regulation and Treatment with Inducers of Transport and Cofactors
Marschall, H., Wagner, M., Zollner, G., & Trauner, M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060133c · Cited by 30
Kepez, A., Oto, A., & Dağdelen, S. (2006) · BioDrugs · doi:10.2165/00063030-200620020-00006 · Cited by 28
Deep Learning Algorithm Based on Molecular Fingerprint for Prediction of Drug‐Induced Liver Injury
Yang, Q., Zhang, S., & Li, Y. (2024) · Toxicology · doi:10.1016/j.tox.2024.153736 · Cited by 29
Metabolic network-based predictions of toxicant-induced metabolite changes in the laboratory rat
Pannala, V. R., Wall, M. L., Estes, S. K., Trenary, I. A., O’Brien, T. P., Printz, R. L., Vinnakota, K. C., Reifman, J., Shiota, M., Young, J. D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30149-7 · Cited by 25
Emerging trends in modeling human liver disease in vitro
Underhill, G. H., & Khetani, S. R. (2019) · APL Bioengineering · doi:10.1063/1.5119090 · Cited by 30
Kang, M.-G., & Kang, N. S. (2021) · Molecules · doi:10.3390/molecules26247548 · Cited by 33
Idiosyncratic Drug-Induced Liver Injury: A Clinical Update
Maddur, H., & Chalasani, N. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0154-8 · Cited by 27
Wenzel, S. E., Busse, W. W., Calhoun, W. J., Panettieri, R. A., Peters-Golden, M., Dubé, L. M., Walton-Bowen, K. L., Russell, H. K., & Harris, J. (2007) · Journal of Asthma · doi:10.1080/02770900701344199 · Cited by 26
New problems arising from old drugs: second-generation effects of acetaminophen
Tiegs, G., Karimi, K., Brune, K., & Arck, P. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.944502 · Cited by 27
Evaluation of an in vitro toxicogenetic mouse model for hepatotoxicity
Martinez, S. M., Bradford, B. U., Soldatow, V. Y., Kosyk, O., Sandot, A., Witek, R. P., Kaiser, R. A., Stewart, T. W., Amaral, K. B., Freeman, K., et al. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.09.012 · Cited by 32
Kakisaka, K., Yoshida, Y., Suzuki, Y., Sato, T., Kuroda, H., Miyasaka, A., & Takikawa, Y. (2017) · Hepatology Research · doi:10.1111/hepr.12893 · Cited by 26
Xu, J., Oda, S., & Yokoi, T. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.01.019 · Cited by 26
Bischoff, K. L., Mukai, M., & Ramaiah, S. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811410-0.00015-5 · Cited by 26
Severe Hepatocellular Injury With Apoptosis Induced by a Hepatitis C Polymerase Inhibitor
Feldstein, A. E., Kleiner, D. E., Kravetz, D., & Buck, M. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318178d91f · Cited by 27
Yoshikawa, Y., Hosomi, H., Fukami, T., Nakajima, M., & Yokoi, T. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.05.024 · Cited by 28
Knockdown of superoxide dismutase 2 enhances acetaminophen-induced hepatotoxicity in rat
Yoshikawa, Y., Morita, M., Hosomi, H., Tsuneyama, K., Fukami, T., Nakajima, M., & Yokoi, T. (2009) · Toxicology · doi:10.1016/j.tox.2009.07.017 · Cited by 27
Chen, J., Li, J., Zhang, Z., Cheng, Y., Wang, Z., Chen, X., She, M., Xie, X., Liu, P., Chen, F., et al. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.135896 · Cited by 25
Liver organoids: updates on generation strategies and biomedical applications
Liu, S., Cheng, C., Zhu, L., Zhao, T., Wang, Z., Yi, X., Yan, F., Wang, X., Li, C., Cui, T., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03865-3 · Cited by 33
Methylprednisolone‐induced liver injury: Case report and literature review
Davidov, Y., Har‐Noy, O., Pappo, O., Achiron, A., Dolev, M., & Ben‐Ari, Z. (2015) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12306 · Cited by 26
Li, A., Li, L., Liu, X., Chen, D., Fan, Y., Lin, H., & Gao, J. (2021) · Chemical Communications · doi:10.1039/d1cc03913j · Cited by 25
Roychoudhury, A., Dear, J. W., Kersaudy-Kerhoas, M., & Bachmann, T. T. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115298 · Cited by 25
Monitoring liver safety in drug development: The GSK experience
Hunt, C. M., Papay, J. I., Edwards, R. I., Theodore, D., Alpers, D., Dollery, C. T., DeBruin, T. W., Adkison, K. K., Stirnadel-Farrant, H. A., & Gibbs, T. (2007) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2007.06.002 · Cited by 27
Dapsone induces oxidative stress and impairs antioxidant defenses in rat liver
Veggi, L. M., Pretto, L., Ochoa, E. J., Catania, V. A., Luquita, M. G., Taborda, D. R., Pozzi, E. J. S., Ikushiro, S., Coleman, M. D., Roma, M. G., et al. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.05.016 · Cited by 27
Thalidomide‐Induced Severe Hepatotoxicity
Hanje, A. J., Shamp, J. L., Thomas, F. B., & Meis, G. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.7.1018 · Cited by 25
Segovia‐Zafra, A., Paz, M. V., Serras, A. S., Matilla‐Cabello, G., Bodoque-García, A., Zeo-Sánchez, D. E. D., Niu, H., Álvarez‐Álvarez, I., Sanz‐Villanueva, L., Godec, S., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.026 · Cited by 25
Liu, F.-C., Yu, H., Chou, A., Lee, H.-C., & Liao, C.-C. (2020) · PubMed · Cited by 33
Drug-mediated toxicity: illuminating the ‘bad’ in the test tube by means of cellular assays?
Tralau, T., & Luch, A. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.015 · Cited by 24
Computational toxicology, friend or foe?
Greene, N., & Pennie, W. D. (2015) · Toxicology Research · doi:10.1039/c5tx00055f · Cited by 25
Soares, A. A., de Oliveira, A. L., de Sá‐Nakanishi, A. B., Comar, J. F., de Santi-Rampazzo, A. P., Vicentini, F., Natali, M. R. M., da Costa, S. M. G., Bracht, A., & Peralta, R. M. (2013) · BioMed Research International · doi:10.1155/2013/469180 · Cited by 25
REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY
Lynch, J. P., Metz, D. C., Schuppan, D., Junker, Y., & Barisani, D. (2009) · Cited by 24
A lipidomic cell‐based assay for studying drug‐induced phospholipidosis and steatosis
García‐Cañaveras, J. C., Peris‐Díaz, M. D., Alcoriza‐Balaguer, M. I., Cerdán‐Calero, M., Donato, M. T., & Lahoz, A. (2017) · Electrophoresis · doi:10.1002/elps.201700079 · Cited by 24
Tan, E. H., Low, E. X. S., Dan, Y. Y., & Tai, B. C. (2018) · Liver International · doi:10.1111/liv.13646 · Cited by 24
Yamamoto, T., Tomizawa, K., Fujikawa, M., Sato, Y., Yamada, H., & Horii, I. (2007) · The Journal of Toxicological Sciences · doi:10.2131/jts.32.205 · Cited by 26
Huang, Q., Yang, T., Song, Y., Sun, W., Xu, J., Cheng, Y., Yin, R., Zhu, L., Zhang, M., Ма, Л., et al. (2024) · Lab on a Chip · doi:10.1039/d3lc00980g · Cited by 24
Oda, S., Uchida, Y., Aleo, M. D., Koza‐Taylor, P., Matsui, Y., Hizue, M., Marroquin, L. D., Whritenour, J., Uchida, E., & Yokoi, T. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02882-4 · Cited by 25
Liver Acinus Dynamic Chip for Assessment of Drug-Induced Zonal Hepatotoxicity
Kwon, D., Choi, G., Park, S.-A., Cho, S., Cho, S., & Ko, S. (2022) · Biosensors · doi:10.3390/bios12070445 · Cited by 30
Hepatotoxic mechanism of cantharidin: insights and strategies for therapeutic intervention
Jin, D., Huang, N., & Wei, J.-X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1201404 · Cited by 23
Lewis, J. H. (2013) · Pharmaceutical Medicine · doi:10.1007/s40290-013-0015-5 · Cited by 24
Geenen, S., Michopoulos, F., Kenna, J. G., Kolaja, K. L., Westerhoff, H. V., & Wilson, I. D. (2010) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2010.11.038 · Cited by 23
Safety biomarkers for drug-induced liver injury – current status and future perspectives
Antoine, D. J., Harrill, A. H., Watkins, P. B., & Park, B. K. (2013) · Toxicology Research · doi:10.1039/c3tx50077b · Cited by 28
Pathway-based toxicity: history, current approaches and liver fibrosis and steatosis as prototypes
Willett, C., Rae, J. C., Goyak, K. O., Landesmann, B., Minsavage, G., & Westmoreland, C. (2014) · ALTEX · doi:10.14573/altex.1401283 · Cited by 24
Dey, P., Dutta, S., Raha, A. B., Sarkar, M. P., & Chaudhuri, T. K. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1260-4 · Cited by 24
Sasaki, E., & Yokoi, T. (2018) · The Journal of Toxicological Sciences · doi:10.2131/jts.43.75 · Cited by 23
Sleno, L., Staack, R. F., Varesio, E., & Gérard Hopfgartner, D. (2007) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3092 · Cited by 23
Liang, X., Zhang, J., Zhu, Y., Lu, Y., Zhou, X., Wang, Z., Yu, J., Yan, Y., Di, L., Che, L., et al. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0936-6 · Cited by 23
Drug-induced hepatotoxicity test using γ-glutamylcysteine synthetase knockdown rat
Morita, M., Akai, S., Hosomi, H., Tsuneyama, K., Nakajima, M., & Yokoi, T. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.05.016 · Cited by 23
Saha, B., & Nandi, D. (2009) · Hepatology · doi:10.1002/hep.23180 · Cited by 24
(2013) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.s1-002 · Cited by 23
Overview of Mechanisms of Drug-Induced Liver Injury (DILI) and Key Challenges in DILI Research
Noureddin, N., & Kaplowitz, N. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_1 · Cited by 28
Self-citationArtificial Intelligence in 3D Printing: A Revolution in Health Care
Banerjee, A., Haridas, H. K., SenGupta, A., & Jabalia, N. (2021) · Lecture notes in bioengineering · doi:10.1007/978-981-33-6703-6_4 · Cited by 32
Hadi, M., Chen, Y., Starokozhko, V., Merema, M. T., & Groothuis, G. M. M. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300248j · Cited by 22
Yamauchi, S., Kiyosawa, N., Ando, Y., Watanabe, K., Niino, N., Ito, K., Yamoto, T., Manabe, S., & Sanbuissho, A. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0632-7 · Cited by 22
Idiosyncratic drug hepatotoxicity: a 2008 update
Andrade, R. J., López-Ortega, S., López‐Vega, M. C., Robles‐Díaz, M., Cueto, I., & Lucena, M. I. (2008) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.1.2.261 · Cited by 27
Toxicidad hepática causada por medicamentos: revisión estucturada
Paniagua, A. C., Posada, L. M. C., & Amariles, P. (2017) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.177 · Cited by 40
Biomarkers of Drug-Induced Liver Toxicity
Neuman, M. G. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000610 · Cited by 25
Nationwide Longitudinal Analysis of Acute Liver Failure in Taiwan
Ho, C., Lee, C., Wang, J., Lee, P., Lai, H., & Hu, R. (2014) · Medicine · doi:10.1097/md.0000000000000035 · Cited by 26
Practical Application of Toxicogenomics for Profiling Toxicant-Induced Biological Perturbations
Kiyosawa, N., Manabe, S., Yamoto, T., & Sanbuissho, A. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11093397 · Cited by 24
Metadata
- Authors
- Kaplowitz, N.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Kaplowitz, Neil
- ORCID
- Kaplowitz, Neil
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-06
- Volume
- 4
- Issue
- 6
- Pages
- 489-499
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2017783406
- Cited by
- 1,054
- References
- 155
- Citations by year
- 2026: 29 · 2025: 35 · 2024: 35 · 2023: 44 · 2022: 31 · 2021: 49 · 2020: 45 · 2019: 48 · 2018: 54 · 2017: 66 · 2016: 72 · 2015: 55 · 2014: 64 · 2013: 57 · 2012: 52
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- drug-induced liver injury, troglitazone, preclinical toxicology, hepatotoxicity prediction, pharmacovigilance, acetaminophen hepatotoxicity, innate immune system, cell death pathways, drug withdrawal, post-marketing surveillance
- MeSH terms
- Animals, Pharmaceutical Preparations, Humans, Liver, Liver Diseases, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.